Paper805382
Ethosuximide in the treatment of absence (peptit mal) seizures.
Browne TR and 7 others. Neurology, 1975. Cited by 115 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ethosuximide in the treatment of absence (peptit mal) seizures. Papers, record 805382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/805382
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epilepsy, Absence | Major topic |
| Ethosuximide | Major topic |
| Adolescent | |
| Child | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Electroencephalography | |
| Female | |
| Half-Life | |
| Humans | |
| Male | |
| Psychological Tests | |
| Wechsler Scales |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,597,542 | Spontaneous epileptiform activity in a rat model of bilateral subcortical band heterotopia. | Epilepsia | 2019 | https://conductscience.org/library/papers/30597542 | PubMed |
| 26,420,483 | Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26420483 | PubMed |
| 23,885,176 | Current and emerging treatments for absence seizures in young patients. | Neuropsychiatr Dis Treat | 2013 | https://conductscience.org/library/papers/23885176 | PubMed |
| 22,670,150 | Cognitive function of idiopathic childhood epilepsy. | Korean J Pediatr | 2012 | https://conductscience.org/library/papers/22670150 | PubMed |
| 22,164,192 | The cognitive impact of antiepileptic drugs. | Ther Adv Neurol Disord | 2011 | https://conductscience.org/library/papers/22164192 | PubMed |
| 17,963,043 | Neuropsychological deficits in childhood epilepsy syndromes. | Neuropsychol Rev | 2007 | https://conductscience.org/library/papers/17963043 | PubMed |
| 17,627,674 | Ethosuximide: from bench to bedside. | CNS Drug Rev | 2007 | https://conductscience.org/library/papers/17627674 | PubMed |
| 15,043,806 | Idiopathic Generalized Epilepsy. | Curr Treat Options Neurol | 2004 | https://conductscience.org/library/papers/15043806 | PubMed |
| 11,393,330 | Treatment of typical absence seizures and related epileptic syndromes. | Paediatr Drugs | 2001 | https://conductscience.org/library/papers/11393330 | PubMed |
| 9,764,957 | Therapeutic drug monitoring--antiepileptic drugs. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9764957 | PubMed |
| 9,634,550 | On the action of the anti-absence drug ethosuximide in the rat and cat thalamus. | J Neurosci | 1998 | https://conductscience.org/library/papers/9634550 | PubMed |
| 8,549,027 | Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/8549027 | PubMed |
| 6,993,208 | Rational usage of therapeutic drug monitoring in antiepileptic treatment. | Eur J Pediatr | 1980 | https://conductscience.org/library/papers/6993208 | PubMed |
| 6,802,548 | Ethosuximide plasma concentrations: influence of age and associated concomitant therapy. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6802548 | PubMed |
| 6,327,221 | Anticonvulsant drugs. An update. | Drugs | 1984 | https://conductscience.org/library/papers/6327221 | PubMed |
| 3,929,323 | Effects of phenobarbital, clonazepam, valproic acid, ethosuximide, and phenytoin on the delayed matching-to-sample performance of pigeons. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3929323 | PubMed |
| 3,311,530 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311530 | PubMed |
| 3,124,180 | Discriminative stimulus properties of ethosuximide in the pigeon. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/3124180 | PubMed |
| 2,182,266 | Therapeutic drug monitoring of anticonvulsants. State of the art. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2182266 | PubMed |
| 2,169,941 | Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction. | Br J Pharmacol | 1990 | https://conductscience.org/library/papers/2169941 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/805382
GET https://conductscience.org/api/papers/v1/805382/cited_by?page=2